May
25
Friday

AMGN 178.24 +0.28 (0.16%)

Sections on this page: Stock Price | Stock Charts | Company Profile | Earnings | Dividend


Would you like to receive important updates about Amgen Inc like earnings dates and more?

Add (AMGN) to Portfolio

AMGN Stock Price Today $178.24

 The recent AMGN stock price today is $178.24 +0.28 (0.16%) for Fri, May 25, 2018.

Year To Date

The Year To Date (YTD) return is +0.70%.

52 Week Low

May 2017
30
Tuesday

The 52 Week Low stock price is 153.56 set on Tue, May 30, 2017 which is 361 days ago.

The current price per share is 16.07% above the 52 week low.

52 Week High

Jan
29
Monday

The 52 Week High stock price is $201.23 set on Mon, Jan 29, 2018 which is 117 days ago.

The current price per share is -11.42% below the 52 week high.

All Time High

Jan
29
Monday

The All Time High stock price is $201.23 set on Mon, Jan 29, 2018 which is 117 days ago.

The current price per share is -11.42% below the all time high.

Amgen Stock Charts

The 5 year and 1 year stock charts are below.

5 Year Stock Chart

The Amgen 5 year stock chart shows the historical prices over the previous 60 months.

Amgen 5 year stock chart

1 Year Stock Chart

The Amgen 1 year stock chart shows the historical prices over the previous 12 months.

Amgen 1 year stock chart

50 Day Moving Average

The 50 Day Moving Average is at $173.51 which is 2.73% below the stock price of $178.24.

200 Day Moving Average

The 200 Day Moving Average is at 178.44 which is -0.11% below the stock price of $178.24.

AMGN Company Profile

Amgen Inc LogoAmgen Inc is a Health Care stock that trades on the NASDAQ and has a market capitalization of $117.76 Billion.

AMGN is also one of the largest companies by market capitalization today.

http://www.amgen.comAmgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

For more information and analysis about Amgen Inc, visit their web site at http://www.amgen.com. For a real time price lookup on this ticker, AMGN, visit Google Finance and Bloomberg.

Below are several other Biotech & Pharma stocks include AbbVie Inc (ABBV), Allergan PLC (AGN), Alexion Pharmaceuticals Inc (ALXN), Amgen Inc (AMGN), Biogen Inc (BIIB), BioMarin Pharmaceutical Inc (BMRN), Bristol-Myers Squibb Co (BMY), Celgene Corp (CELG), Endo International PLC (ENDP), Gilead Sciences Inc (GILD), .

AMGN Earnings

 Below is the EPS, P/E Ratio and Earnings Date.

Earnings Per Share

The EPS is $2.69.

Price To Earnings Ratio

The P/E Ratio is 66.26

Earnings Dates

Stocks can make big percentage moves on the earnings announcement.

Companies announce earnings either before the market open or after the close.

Feb
01
Thursday

The Earnings Release Date for Amgen Inc was Thu, Feb 1, 2018.

Since this earnings release 114 days ago, the stock price is down by -4.20%.

Apr
24
Tuesday

The most recent Earnings Release Date was on Tue, Apr 24, 2018, which was 32 days ago.

Since this earnings date, the stock price is up by +2.05%.

Amgen Dividend

 Below is the Dividend Yield, Ex-Date and Pay Date.

Dividend Yield

The Annual Dividend Yield is 2.96%.

Check out the Dividend Calculator to forecast your potential profis with Amgen.

Ex-Dividend Date

May
16
Wednesday

Since the Ex-Date on Wed, May 16, 2018, 10 days ago, the stock price is up by 6.45%.

(The next ex-dividend date will be around Tue, Aug 14, 2018.)